32. Olsen MA, Stwalley D, Demont C, Dubberke ER. Clostridium difficile infection increases acute and chronic morbidity and mortality. Infect Control Hosp Epidemiol. 2019;40(1):65‐71. 33. Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC. Attributable burden of hospital‐onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol. 2013;34(6):588‐96. 34. Mlangeni DA, Harris MD, Franklin L, Hunt P, Karas JA, Enoch DA. Death certificates provide a poor estimation of attributable mortality due to Clostridium difficile when compared to a death review panel using defined criteria. J Hosp Infect. 2011;77(4):370‐1. 35. Rhodes A, Ferdinande P, Flaatten H, Guidet B, Metnitz PG, Moreno RP. The variability of critical care bed numbers in Europe. Intensive Care Med. 2012;38(10):1647‐53. 36. Hansen S, Zingg W, Ahmad R, Kyratsis Y, Behnke M, Schwab F, et al. Organization of infection control in European hospitals. J Hosp Infect. 2015;91(4):338‐45. 37. Morgan DJ, Lomotan LL, Agnes K, McGrail L, Roghmann MC. Characteristics of healthcare‐ associated infections contributing to unexpected in‐hospital deaths. Infect Control Hosp Epidemiol. 2010;31(8):864‐6. 6 141 Mortality review reproducibility study
RkJQdWJsaXNoZXIy MTk4NDMw